Michael S Kitchen, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 410 New St, Manning, SC 29102 Phone: 803-435-8710 |
Donald L. Miller, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 E Hospital St, Manning, SC 29102 Phone: 803-435-5248 Fax: 803-435-5288 |
Robert W Rhame Jr., MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 E Hospital Street, Emergency Department, Manning, SC 29102 Phone: 803-435-8463 |
Marva Denise Williams, MD Emergency Medicine - Emergency Medical Services Medicare: Accepting Medicare Assignments Practice Location: 107 Sunset Dr, Manning, SC 29102 Phone: 803-435-4447 Fax: 803-435-9092 |
Gamal A Elsaidi, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 E Hospital Street, Emergency Dept, Manning, SC 29102 Phone: 803-435-8463 |
Dr. Jeffrey Stephen Anderson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 S Brooks St, Manning, SC 29102 Phone: 800-926-3772 |
News Archive
The German Research Foundation has established a new Collaborative Research Center on "Nanodimensional polymer therapeutics for tumor therapy" (CRC 1066) at Johannes Gutenberg University Mainz and the Max Planck Institute for Polymer Research (MPI-P).
Young people considering a career in medicine will receive expert advice this weekend to help them on the route to achieving their ambitions and to consider psychiatry as an exciting medical discipline.
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Parallax® Contour® Vertebral Augmentation Device (Contour) specifically for void creation in a vertebral body followed by injection of bone cement. Vertebral body void creation followed by bone cement augmentation is commonly used to treat painful vertebral compression fractures.
Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing first-in-class drugs to treat serious or life-threatening unmet medical conditions, today announced that it closed on $5.9 million in additional private financing during the second half of 2009, bringing the total the company raised in 2009 to $7.1 million.
› Verified 3 days ago